Literature DB >> 8649541

Lumboperitoneal shunt for the treatment of pseudotumor cerebri.

E R Eggenberger1, N R Miller, S Vitale.   

Abstract

We conducted a retrospective study of 27 patients with pseudotumor cerebri (PTC) treated with at least one lumboperitoneal shunt (LPS) to ascertain the efficacy of this treatment. The average duration of follow-up for this population was 77 months (median, 47 months), with a range of 21 to 278 months. A functioning LPS was successful in alleviating symptoms in all patients studied, and no patient with a functioning shunt complained of shunt-related symptoms, such as low-pressure headache or abdominal pain, within 2 months after the shunt was performed. Twelve patients (44%) required no revisions. The number of revisions among the 15 patients (56%) who required them ranged from 1 (5 patients) to 13 (1 patient). Three of these patients required 35 of the 66 total shunt revisions (53%). There were no major complications from LPS, other than failure of the shunt, even in patients who required multiple shunts. We conclude that placement of a lumboperitoneal shunt is satisfactory treatment for the majority of patients with PTC who require surgical therapy for the disorder, even though some patients ultimately require multiple shunt revisions.

Entities:  

Mesh:

Year:  1996        PMID: 8649541     DOI: 10.1212/wnl.46.6.1524

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  Idiopathic Intracranial Hypertension.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  Lumboperitoneal shunt for idiopathic intracranial hypertension: patients' selection and outcome.

Authors:  Waleed F El-Saadany; Ahmed Farhoud; Ihab Zidan
Journal:  Neurosurg Rev       Date:  2011-09-29       Impact factor: 3.042

Review 3.  Pseudotumor cerebri.

Authors:  Pietro Spennato; Claudio Ruggiero; Raffaele Stefano Parlato; Maria Consiglio Buonocore; Antonio Varone; Emilio Cianciulli; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2010-08-19       Impact factor: 1.475

Review 4.  Diagnosis and management of benign intracranial hypertension.

Authors:  D Soler; T Cox; P Bullock; D M Calver; R O Robinson
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

5.  Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension.

Authors:  S J Hickman; N Raoof; H Panesar; J M McMullan; I M Pepper; B Sharrack
Journal:  Neuroophthalmology       Date:  2014-11-12

6.  Idiopathic Intracranial Hypertension.

Authors:  Robert K. Shin; Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2002-07       Impact factor: 3.598

7.  Clinical profile, evaluation, management and visual outcome of idiopathic intracranial hypertension in a neuro-ophthalmology clinic of a tertiary referral ophthalmic center in India.

Authors:  S Ambika; Deepak Arjundas; Veena Noronha
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

8.  Meta-Analysis of CSF Diversion Procedures and Dural Venous Sinus Stenting in the Setting of Medically Refractory Idiopathic Intracranial Hypertension.

Authors:  S R Satti; L Leishangthem; M I Chaudry
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

Review 9.  Headache and the pseudotumor cerebri syndrome.

Authors:  Robert M Mallery; Deborah I Friedman; Grant T Liu
Journal:  Curr Pain Headache Rep       Date:  2014-09

Review 10.  CSF diversion in refractory idiopathic intracranial hypertension: single-centre experience and review of efficacy.

Authors:  Georgios Niotakis; Dionysios Grigoratos; Chris Chandler; Danny Morrison; Ming Lim
Journal:  Childs Nerv Syst       Date:  2012-08-24       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.